RSV prophylaxis/ Niservimab-Beyfortus

Introducing Nirsevimab (Beyfortus): A Breakthrough in RSV Prevention In recent weeks, a remarkable tool has emerged in our fight against the Respiratory Syncytial Virus (RSV). Nirsevimab, known by its brand name Beyfortus, has garnered both FDA approval and a CDC recommendation, marking a significant advancement in our ability to prevent hospitalizations and fatalities related to…